Biodesix Inc stock is traded at $9.88, with a volume of 386,397. It is up +0.92% in the last 24 hours and down -58.24% over the past month. Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
Previous Close:
$9.79
Open:
$10.06
24h Volume:
386,397
Relative Volume:
0.81
Market Cap:
$109.55M
Revenue:
$96.10M
Net Income/Loss:
-$31.96M
P/E Ratio:
-
EPS:
-$4.03
Net Cash Flow:
-$25.27M
1W Performance:
-4.45%
1M Performance:
-58.24%
6M Performance:
-30.28%
1Y Performance:
+23.50%
1-Day Range:
$9.85$11.32
1-Week Range:
$9.39$11.32
52-Week Range:
$5.26$31.97
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
303-417-0500Address
919 WEST DILLON ROAD, LOUISVILLE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS